Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:24 Mar 2017 09:38:00 AM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1270.30 [ -0.24% ]TCS 2455.00 [ -0.22% ]

Sensex29454.41
122.25 0.42%

Nifty9116.85
30.55 0.34%

Midcap13905.71
52.31 0.38%

Smallcap14119.58
91.64 0.65%


Bse Corporate Announcements Back
Pharma Announces Positive Results of Two Pivotal Phase-3 Clinical Trials of Tildrakizumab
Sun Pharma announced that two pivotal Phase-3 clinical trials evaluating the efficacy and safety of the investigational IL-23p19 inhibitor antibody tildrakizumab (MK-3222) in patients with moderate-to-severe plaque psoriasis met their primary endpoints for both evaluated doses.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com